Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
NEUROSCIENCE: Stout Guards of the Central Nervous System
R. Mechoulam and A. H. Lichtman
Endocannabinoids have paradoxical effects on the mammalian nervous system: Sometimes they block neuronal excitability and other times they augment it. In their Perspective, Mechoulam and Lichtman discuss new work (Marsicano et al.) showing that activation of the cannabinoid receptor CB1 by the endocannabinoid anandamide protects against excitotoxic damage in a mouse model of kainic acid-induced epilepsy.
R. Mechoulam is in the Department of Medicinal Chemistry and Natural Products, Medical Faculty, Hebrew University, Jerusalem 91120, Israel. E-mail: mechou{at}cc.huji.ac.il A. H. Lichtman is in the Department of Pharmacology/Toxicology, Virginia Commonwealth University-Medical College of Virginia, Richmond, VA 23298, USA. E-mail: alichtma{at}hsc.vcu.edu
Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus.
A. Ludanyi, L. Eross, S. Czirjak, J. Vajda, P. Halasz, M. Watanabe, M. Palkovits, Z. Magloczky, T. F. Freund, and I. Katona (2008)
J. Neurosci.
28, 2976-2990
|Abstract »|Full Text »|PDF »
Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure-Induced Ischemia in Rats.
C. Nucci, V. Gasperi, R. Tartaglione, A. Cerulli, A. Terrinoni, M. Bari, C. De Simone, A. F. Agro, L. A. Morrone, M. T. Corasaniti, et al. (2007)
Invest. Ophthalmol. Vis. Sci.
48, 2997-3004
|Abstract »|Full Text »|PDF »
